Drug Safety Matters

#2 Why we should listen to patients – Linda Härmark

May 20, 2020 Uppsala Monitoring Centre
Drug Safety Matters
#2 Why we should listen to patients – Linda Härmark
Chapters
Drug Safety Matters
#2 Why we should listen to patients – Linda Härmark
May 20, 2020
Uppsala Monitoring Centre

As the end users of medicines, patients can provide first-hand information on side effects. The issues they report add a richness to our understanding of medicine safety that we could never achieve by relying on healthcare professionals’ reports alone – so it’s crucial that we listen to them. Linda Härmark from the Netherlands pharmacovigilance centre Lareb tells us more.

Tune in to find out:

  • What patient reports reveal about people’s use of medicines
  • How to make best use of the information relayed by patients
  • What to consider when setting up a patient reporting system

Want to know more?

Here are a few reading resources to get you started:

Join the conversation on social media
Follow us on Twitter, Facebook or LinkedIn, and share your thoughts about the show with the hashtag #DrugSafetyMatters.

Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!

About UMC
Read more about Uppsala Monitoring Centre and how we work to make medicines safer for patients.

Show Notes

As the end users of medicines, patients can provide first-hand information on side effects. The issues they report add a richness to our understanding of medicine safety that we could never achieve by relying on healthcare professionals’ reports alone – so it’s crucial that we listen to them. Linda Härmark from the Netherlands pharmacovigilance centre Lareb tells us more.

Tune in to find out:

  • What patient reports reveal about people’s use of medicines
  • How to make best use of the information relayed by patients
  • What to consider when setting up a patient reporting system

Want to know more?

Here are a few reading resources to get you started:

Join the conversation on social media
Follow us on Twitter, Facebook or LinkedIn, and share your thoughts about the show with the hashtag #DrugSafetyMatters.

Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!

About UMC
Read more about Uppsala Monitoring Centre and how we work to make medicines safer for patients.